Limited infection upon human exposure to a recombinant raccoon pox vaccine vector
January 1, 2004
A laboratory accident resulted in human exposure to a recombinant raccoon poxvirus (RCN) developed as a vaccine vector for antigens of Yersinia pestis for protection of wild rodents (and other animals) against plague. Within 9 days, the patient developed a small blister that healed within 4 weeks. Raccoon poxvirus was cultured from the lesion, and the patient developed antibody to plague antigen (F1) and RCN. This is the first documented case of human exposure to RCN.
Citation Information
| Publication Year | 2004 |
|---|---|
| Title | Limited infection upon human exposure to a recombinant raccoon pox vaccine vector |
| DOI | 10.1016/j.vaccine.2004.01.030 |
| Authors | T.E. Rocke, F. J. Dein, M. Fuchsberger, B.C. Fox, D.T. Stinchcomb, J.G. Osorio |
| Publication Type | Article |
| Publication Subtype | Journal Article |
| Series Title | Vaccine |
| Index ID | 1003795 |
| Record Source | USGS Publications Warehouse |
| USGS Organization | National Wildlife Health Center |